The School of Pharmacy, University of London

The School of Pharmacy, University of London is a university in London, United Kingdom that has taken part in 10 EU-funded projects since 2008, receiving €1.8M in EU funding.

EU funding received€1.8M
EU projects10
As coordinator0
Running now0
First EU project2008
Latest project2011
CountryUnited Kingdom
EU registration (PIC)999864749
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are The School of Pharmacy, University of London's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€1.8M · 10 projects

Projects

10 EU-funded projects, newest first. Each links to the official record.

  • NANORESISTANCEPartner

    Management of Resistance to Tyrosine Kinase Inhibitors with Advanced Nanosystems

    FP7 (2007 to 2013) · 2011–2015 · Project on CORDIS ↗

  • NANONEUROHOPPartner

    Assessment of the hazard and opportunities of using carbon nanotubes as a new nanocarrier for drug delivery in neural tissue

    FP7 (2007 to 2013) · 2011–2013 · Project on CORDIS ↗

  • GRIPPartner

    Global Research in Paediatrics

    FP7 (2007 to 2013) · 2011–2017 · Project on CORDIS ↗

  • DEEPPartner

    DEferiprone Evaluation in Paediatrics

    FP7 (2007 to 2013) · 2011–2016 · Project on CORDIS ↗

    €2ktheir share
  • ADDUCEPartner

    Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects

    FP7 (2007 to 2013) · 2010–2016 · Project on CORDIS ↗

    €172ktheir share
  • STOPPartner

    Suicidality: Treatment Occurring in Paediatrics

    FP7 (2007 to 2013) · 2010–2015 · Project on CORDIS ↗

    €85ktheir share
  • PERSPartner

    Paediatric European Risperidone Studies

    FP7 (2007 to 2013) · 2010–2015 · Project on CORDIS ↗

    €164ktheir share
  • SONODRUGSPartner

    Image-controlled Ultrasound-induced Drug Delivery

    FP7 (2007 to 2013) · 2008–2012 · Project on CORDIS ↗

    €974ktheir share
  • CONTAMEDPartner

    Contaminant mixtures and human reproductive health - novel strategies for health impact and risk assessment of endocrine disrupters

    FP7 (2007 to 2013) · 2008–2012 · Project on CORDIS ↗

    €405ktheir share
  • ESNATSPartner

    Embryonic Stem cell-based Novel Alternative Testing Strategies

    FP7 (2007 to 2013) · 2008–2013 · Project on CORDIS ↗

    €2ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • asthma
  • automation
  • cardiovascular diseases
  • databases
  • drug discovery
  • drug safety
  • magnetic resonance imaging
  • mathematical model
  • nanomedicine
  • nanotechnology
  • neurobiology
  • oncology
  • paediatrics
  • pharmaceutical drugs

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime